PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY
To provide a pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof having excellent properties.SOLUTION: A pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof is provided in which HCDR1 includes an amino acid sequence of SEQ...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WADA KOICHI SAKATA TOMOKO SHIGEMITSU TAKANARI IMURA YUICHI SAITO KENJI MIYAMOTO YUYA |
| description | To provide a pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof having excellent properties.SOLUTION: A pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof is provided in which HCDR1 includes an amino acid sequence of SEQ ID NO: 1, HCDR2 includes an amino acid sequence of SEQ ID NO: 2, HCDR3 includes an amino acid sequence of SEQ ID NO: 3, LCDR1 includes an amino acid sequence of SEQ ID NO: 4, LCDR2 includes an amino acid sequence of SEQ ID NO: 5, and LCDR3 includes an amino acid sequence of SEQ ID NO: 6.SELECTED DRAWING: Figure 1
【課題】優れた特性を有する抗PAD4抗体又はその抗体断片を含む医薬組成物を提供すること。【解決手段】HCDR1が配列番号１のアミノ酸配列を含み、HCDR2が配列番号２のアミノ酸配列を含み、HCDR3が配列番号３のアミノ酸配列を含み、LCDR1が配列番号４のアミノ酸配列を含み、LCDR2が配列番号５のアミノ酸配列を含み、LCDR3が配列番号６のアミノ酸配列を含む、抗PAD4抗体又はその抗体断片、を含む医薬組成物、を提供する。【選択図】図１ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2024028198A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2024028198A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2024028198A3</originalsourceid><addsrcrecordid>eNrjZLAN8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Pw9HP2CXXx9HNX8PMPc_VRcPQL8dQNcHQxAbOc_F0ieRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGRiYGRhaGlhaMxUYoAmdMqdA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY</title><source>esp@cenet</source><creator>WADA KOICHI ; SAKATA TOMOKO ; SHIGEMITSU TAKANARI ; IMURA YUICHI ; SAITO KENJI ; MIYAMOTO YUYA</creator><creatorcontrib>WADA KOICHI ; SAKATA TOMOKO ; SHIGEMITSU TAKANARI ; IMURA YUICHI ; SAITO KENJI ; MIYAMOTO YUYA</creatorcontrib><description>To provide a pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof having excellent properties.SOLUTION: A pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof is provided in which HCDR1 includes an amino acid sequence of SEQ ID NO: 1, HCDR2 includes an amino acid sequence of SEQ ID NO: 2, HCDR3 includes an amino acid sequence of SEQ ID NO: 3, LCDR1 includes an amino acid sequence of SEQ ID NO: 4, LCDR2 includes an amino acid sequence of SEQ ID NO: 5, and LCDR3 includes an amino acid sequence of SEQ ID NO: 6.SELECTED DRAWING: Figure 1
【課題】優れた特性を有する抗PAD4抗体又はその抗体断片を含む医薬組成物を提供すること。【解決手段】HCDR1が配列番号１のアミノ酸配列を含み、HCDR2が配列番号２のアミノ酸配列を含み、HCDR3が配列番号３のアミノ酸配列を含み、LCDR1が配列番号４のアミノ酸配列を含み、LCDR2が配列番号５のアミノ酸配列を含み、LCDR3が配列番号６のアミノ酸配列を含む、抗PAD4抗体又はその抗体断片、を含む医薬組成物、を提供する。【選択図】図１</description><language>eng ; jpn</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240301&DB=EPODOC&CC=JP&NR=2024028198A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240301&DB=EPODOC&CC=JP&NR=2024028198A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WADA KOICHI</creatorcontrib><creatorcontrib>SAKATA TOMOKO</creatorcontrib><creatorcontrib>SHIGEMITSU TAKANARI</creatorcontrib><creatorcontrib>IMURA YUICHI</creatorcontrib><creatorcontrib>SAITO KENJI</creatorcontrib><creatorcontrib>MIYAMOTO YUYA</creatorcontrib><title>PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY</title><description>To provide a pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof having excellent properties.SOLUTION: A pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof is provided in which HCDR1 includes an amino acid sequence of SEQ ID NO: 1, HCDR2 includes an amino acid sequence of SEQ ID NO: 2, HCDR3 includes an amino acid sequence of SEQ ID NO: 3, LCDR1 includes an amino acid sequence of SEQ ID NO: 4, LCDR2 includes an amino acid sequence of SEQ ID NO: 5, and LCDR3 includes an amino acid sequence of SEQ ID NO: 6.SELECTED DRAWING: Figure 1
【課題】優れた特性を有する抗PAD4抗体又はその抗体断片を含む医薬組成物を提供すること。【解決手段】HCDR1が配列番号１のアミノ酸配列を含み、HCDR2が配列番号２のアミノ酸配列を含み、HCDR3が配列番号３のアミノ酸配列を含み、LCDR1が配列番号４のアミノ酸配列を含み、LCDR2が配列番号５のアミノ酸配列を含み、LCDR3が配列番号６のアミノ酸配列を含む、抗PAD4抗体又はその抗体断片、を含む医薬組成物、を提供する。【選択図】図１</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAN8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Pw9HP2CXXx9HNX8PMPc_VRcPQL8dQNcHQxAbOc_F0ieRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGRiYGRhaGlhaMxUYoAmdMqdA</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>WADA KOICHI</creator><creator>SAKATA TOMOKO</creator><creator>SHIGEMITSU TAKANARI</creator><creator>IMURA YUICHI</creator><creator>SAITO KENJI</creator><creator>MIYAMOTO YUYA</creator><scope>EVB</scope></search><sort><creationdate>20240301</creationdate><title>PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY</title><author>WADA KOICHI ; SAKATA TOMOKO ; SHIGEMITSU TAKANARI ; IMURA YUICHI ; SAITO KENJI ; MIYAMOTO YUYA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2024028198A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WADA KOICHI</creatorcontrib><creatorcontrib>SAKATA TOMOKO</creatorcontrib><creatorcontrib>SHIGEMITSU TAKANARI</creatorcontrib><creatorcontrib>IMURA YUICHI</creatorcontrib><creatorcontrib>SAITO KENJI</creatorcontrib><creatorcontrib>MIYAMOTO YUYA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WADA KOICHI</au><au>SAKATA TOMOKO</au><au>SHIGEMITSU TAKANARI</au><au>IMURA YUICHI</au><au>SAITO KENJI</au><au>MIYAMOTO YUYA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY</title><date>2024-03-01</date><risdate>2024</risdate><abstract>To provide a pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof having excellent properties.SOLUTION: A pharmaceutical composition including an anti-PAD4 antibody or an antibody fragment thereof is provided in which HCDR1 includes an amino acid sequence of SEQ ID NO: 1, HCDR2 includes an amino acid sequence of SEQ ID NO: 2, HCDR3 includes an amino acid sequence of SEQ ID NO: 3, LCDR1 includes an amino acid sequence of SEQ ID NO: 4, LCDR2 includes an amino acid sequence of SEQ ID NO: 5, and LCDR3 includes an amino acid sequence of SEQ ID NO: 6.SELECTED DRAWING: Figure 1
【課題】優れた特性を有する抗PAD4抗体又はその抗体断片を含む医薬組成物を提供すること。【解決手段】HCDR1が配列番号１のアミノ酸配列を含み、HCDR2が配列番号２のアミノ酸配列を含み、HCDR3が配列番号３のアミノ酸配列を含み、LCDR1が配列番号４のアミノ酸配列を含み、LCDR2が配列番号５のアミノ酸配列を含み、LCDR3が配列番号６のアミノ酸配列を含む、抗PAD4抗体又はその抗体断片、を含む医薬組成物、を提供する。【選択図】図１</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2024028198A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITION INCLUDING NOVEL ANTI-PAD4 ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A00%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WADA%20KOICHI&rft.date=2024-03-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2024028198A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |